Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Key takeaways Retatrutide is an investigational drug that has not yet been FDA-approved
While they can be lifesaving in acute or emergency settings, repeated or long-term use is associated with well-documented steroid side effects affecting metabolic, immune, and musculoskeletal systems
Mildness: Avoid ingredients that may irritate the formula to ensure the product is gentle, especially for sensitive skin
Some patients find success switching from Thursday to Monday injections to align with their weekly habits, or exploring oral semaglutide ($289 monthly) if needle-based administration consistently causes scheduling conflicts
Side effects may increase temporarily as your body adjusts to the higher amount
Tirzepatide is currently only available on the NHS in England and Wales via specialist weight management services, with a phased roll out to primary care settings in England including GPs
